Energy Production
3X is a compact, operator-controlled ultraviolet pulse generator delivering high-intensity pulsed output, adjustable to the treatment area, for rapid disinfection of large areas from pathogens (COVID-19, African swine fever, bird flu, tuberculosis, salmonella, and other infections).
Technology brief
3X is a compact, operator-controlled ultraviolet pulse generator delivering high-intensity pulsed output, adjustable to the treatment area, for rapid disinfection of large areas from pathogens (COVID-19, African swine fever, bird flu, tuberculosis, salmonella, and other infections).
The challenge
Primary use cases: crowded public spaces (train stations, schools, hospitals, banks, retail); agricultural pathogen control (ASF, bird flu); emergency response; pandemic preparedness. Industries and users: public health authorities, agriculture ministries, emergency management, large facilities. Scale: high-output system with area coverage adjustable per deployment, from single rooms to large public venues.
ARBOK solution
3X is a compact, operator-controlled ultraviolet pulse generator delivering high-intensity pulsed output, adjustable to the treatment area, for rapid disinfection of large areas from pathogens (COVID-19, African swine fever, bird flu, tuberculosis, salmonella, and other infections). A single system eliminates 100% of pathogens in a short pulse-based treatment cycle across indoor and outdoor spaces. Safe for humans and animals; sanitation occurs without personnel present. Deployable on robotic platforms. Fully autonomous operation. No analogs exist globally; high export potential.
Generates intense UV pulses at controlled frequency and intensity; UV radiation (germicidal spectrum) penetrates cell walls of bacteria, viruses, and fungi, destroying DNA/RNA and rendering pathogens inert. Single or double-pulse protocol eliminates pathogens within seconds. System includes innovative pre- and post-treatment pathogenic-air locator for verification. Operator-controlled (single person); powered by mains or batteries. Zero residual chemical. No personnel required during treatment.
Market and application
Pandemic prevention, agricultural disease control, and public health infrastructure are global priorities. Estimated market: thousands of units globally; addressable $2–5 billion over 5–10 years. No competitive technology exists; early adopters in EU, USA, Asia.
CAPEX: €500k–2M per unit (depending on mobile platform integration). OPEX: minimal (electricity only). Cost per treatment: <€10. ROI: positive within 1–2 years for high-volume deployments (hospitals, airports, food processing).
Use cases
Primary use cases: crowded public spaces (train stations, schools, hospitals, banks, retail); agricultural pathogen control (ASF, bird flu); emergency response; pandemic preparedness. Industries and users: public health authorities, agriculture ministries, emergency management, large facilities. Scale: high-output system with area coverage adjustable per deployment, from single rooms to large public venues.
Deployment follows a straightforward sequence: site assessment, unit positioning, single-operator activation, pulse-based treatment, and verification via the integrated locator. Personnel evacuate the treated area during the process, and a full deployment cycle is fast enough to allow the unit to be redeployed to the next site within the same working session.
Compatible with robotic platforms (autonomous vacuum-cleaner-type robots); integrates with HVAC systems for air disinfection; deployable in existing facilities without modification.
3X is a compact, operator-controlled ultraviolet pulse generator delivering high-intensity pulsed output, adjustable to the treatment area, for rapid disinfection of large areas from pathogens (COVID-19, African swine fever, bird flu, tuberculosis, salmonella, and other infections). A single system eliminates 100% of pathogens in a short pulse-based treatment cycle across indoor and outdoor spaces. Safe for humans and animals; sanitation occurs without personnel present. Deployable on robotic platforms. Fully autonomous operation. No analogs exist globally; high export potential.
Primary use cases: crowded public spaces (train stations, schools, hospitals, banks, retail); agricultural pathogen control (ASF, bird flu); emergency response; pandemic preparedness. Industries and users: public health authorities, agriculture ministries, emergency management, large facilities. Scale: high-output system with area coverage adjustable per deployment, from single rooms to large public venues.
Generates intense UV pulses at controlled frequency and intensity; UV radiation (germicidal spectrum) penetrates cell walls of bacteria, viruses, and fungi, destroying DNA/RNA and rendering pathogens inert. Single or double-pulse protocol eliminates pathogens within seconds. System includes innovative pre- and post-treatment pathogenic-air locator for verification. Operator-controlled (single person); powered by mains or batteries. Zero residual chemical. No personnel required during treatment.
| Parameter | Value |
|---|---|
| Power | High-intensity pulsed output, adjustable to treatment area |
| Treatment cycles | Single- or double-pulse protocol, delivered in rapid succession |
| Coverage | Entire room / outdoor area (adjustable per frequency and intensity) |
| Efficacy | 100% pathogen elimination (verified for COVID, ASF, bird flu, tuberculosis, salmonella) |
| Personnel safety | Zero risk; automated lockdown during treatment |
| Treatment time | Full cycle completes within seconds |
| Portability | Compact unit; mountable on robotic platforms |
High-intensity UV pulse generator; UV lamp array; pulse control electronics; integrated pathogenic-air locator (pre/post-treatment verification); operator interface; safety interlocks; mains/battery power supply. Modular, deployable standalone or on mobile platform.
Technical: instant pathogen elimination; 100% efficacy; no consumables; no residual chemicals; safe for humans/animals; automated. Economic: rapid deployment; no ongoing treatment costs; single-operator control; reusable across multiple locations. Environmental: zero chemical discharge; no waste byproducts. Strategic: pandemic-ready; applicable to multiple pathogen types; no global analogs; export potential.
Compatible with robotic platforms (autonomous vacuum-cleaner-type robots); integrates with HVAC systems for air disinfection; deployable in existing facilities without modification.
Deployment follows a straightforward sequence: site assessment, unit positioning, single-operator activation, pulse-based treatment, and verification via the integrated locator. Personnel evacuate the treated area during the process, and a full deployment cycle is fast enough to allow the unit to be redeployed to the next site within the same working session.
TRL 8 — System complete and qualified. Working prototype (Ukraine) tested and operational. Requires: international certification (European/international patents), technical documentation, and final steps toward mass production.
Pandemic prevention, agricultural disease control, and public health infrastructure are global priorities. Estimated market: thousands of units globally; addressable $2–5 billion over 5–10 years. No competitive technology exists; early adopters in EU, USA, Asia.
CAPEX: €500k–2M per unit (depending on mobile platform integration). OPEX: minimal (electricity only). Cost per treatment: <€10. ROI: positive within 1–2 years for high-volume deployments (hospitals, airports, food processing).
Regulatory approval required (UV safety, pathogen elimination claims). Personnel training needed. Integration with existing infrastructure (HVAC, robotics). Long-term UV lamp durability. Perception/acceptance in some markets.
ARBOK-Purification · SkyManager · Ultraviolet Systems · Ultraviolet-Pulse-Generator-3X
Related technologies
represents a novel approach to quantum computing using photonic (light-based) qubits and optical gates instead of traditional superconducting or trapped-ion approaches.
is a liquid ceramic thermal-insulation coating based on acrylic polymers and ultra-fine hollow ceramic microspheres.
LAFA is not a standalone hydrogen system.
Partnership pathway